Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL713293

Cn1ccnc1COc1cc(OCCCOc2ccc(F)cc2)cc(-c2nc3cccnc3[nH]2)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CYP1A1 P04798 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP1B1 Q16678 1/20 0.35
NAMPT P43490 1/20 0.35
CACNA1B Q00975 3/20 0.35
HCAR2 Q8TDS4 1/20 0.34
KDM4E B2RXH2 1/20 0.34
DRD2 P14416 2/20 0.33
DRD3 P35462 2/20 0.33
HDAC3 O15379 2/20 0.33
HDAC4 P56524 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC7 Q8WUI4 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL709074 0.93 NAMPT (0.36) MEN1KMT2ACASP3SENP8SENP6
SCHEMBL9071852 0.93 NPC1 (0.40) MEN1KMT2ACASP3SENP8SENP6
Trifluoroacetic Acid SCHEMBL718789 0.90 PDE4A (0.35) MEN1KMT2ANAMPTKDM4EHDAC3
Trifluoroacetic Acid SCHEMBL712705 0.89 CACNA1B (0.36) MEN1KMT2ACASP3SENP8SENP6
Trifluoroacetic Acid SCHEMBL711889 0.89 HDAC3 (0.34) HDAC3HDAC4HDAC1HDAC7HDAC2
Trifluoroacetic Acid SCHEMBL709575 0.89 SYK (0.34) MEN1KMT2ACASP3SENP8SENP6
Trifluoroacetic Acid SCHEMBL711960 0.89 LMNA (0.37) CASP3SENP8SENP6HCAR2DRD2
Trifluoroacetic Acid SCHEMBL712600 0.88 FAAH (0.38) FFAR1
Trifluoroacetic Acid SCHEMBL708256 0.88 GUCY1B2 (0.36) MEN1KMT2ACASP3SENP8SENP6
Trifluoroacetic Acid SCHEMBL711504 0.86 NOS1 (0.35) MEN1KMT2AKDM4EFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940837-B1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2012-11-07 EP disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 US disclosed
EP-1940837-A2 IMIDAZOPYRIDINE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2008-07-09 EP disclosed
WO-2007028135-A2 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS GCK, GCKR, KHK MEN1 2868/4885KMT2A 2502/4885CASP3 3452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.